Surgery Partners, Inc. announced its financial results for the third quarter ended September 30, 2024, reporting total revenues of $770.4 million. This represents a 14.3% increase compared to the same period in the prior year, driven by growth across its network of surgical facilities.
Same-facility revenues for the quarter increased by 4.2%, with a 3.7% rise in same-facility cases. Despite the top-line growth, the company reported a net loss attributable to Surgery Partners, Inc. of $31.7 million for the quarter.
Adjusted EBITDA reached $128.6 million, reflecting ongoing operational performance. However, the company's adjusted earnings of $0.19 per share and a GAAP loss of $0.25 per share missed Wall Street expectations for the period.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.